 |
Oxymorphone |
|---|---|
| Trade Name | Numorphan H.P. |
| Orphan Indication | For relief of severe intractable pain in narcotic-tolerant patients |
| USA Market Approval | USA |
| USA Designation Date | 1985-03-19 00:00:00 |
| Sponsor | DuPont Merck Pharmaceutical Company;P.O. Box 80027;Wilmington, Delaware, 19880 |
